Royce & Associates LP Stevanato Group S.P.A. Transaction History
Royce & Associates LP
- $10.8 Billion
- Q1 2024
A detailed history of Royce & Associates LP transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Royce & Associates LP holds 369,038 shares of STVN stock, worth $6.77 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
369,038
Previous 420,192
12.17%
Holding current value
$6.77 Million
Previous $11.5 Million
3.31%
% of portfolio
0.11%
Previous 0.11%
Shares
10 transactions
Others Institutions Holding STVN
# of Institutions
154Shares Held
52.2MCall Options Held
5.8KPut Options Held
2.5K-
Conestoga Capital Advisors, LLC6.78MShares$124 Million3.17% of portfolio
-
Neuberger Berman Group LLC New York, NY4.4MShares$80.6 Million0.12% of portfolio
-
Copeland Capital Management, LLC2.4MShares$44.1 Million1.42% of portfolio
-
Lazard Asset Management LLC New York, NY2.27MShares$41.6 Million0.09% of portfolio
-
Wellington Management Group LLP Boston, MA2.21MShares$40.5 Million0.01% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $4.85B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...